2seventy bio, Inc.
TSVTDelisted May 13, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860782
2seventy bio, Inc. was delisted on May 13, 2025; its insiders filed their last Form 4 on May 15, 2025; 140 institutions reported holding it in 13F filings for Q1 2025, worth $234.5M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding 2seventy bio, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 147 | 150 | +3 |
| Shares | 49.8M | 49.9M | +79.4K (+0.2%) |
| Value | $508.0M | $504.8M | −$3.26M (−0.6%) |
New holders (25)
Institutions that held 2seventy bio, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (22)
Institutions that held 2seventy bio, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Balyasny Asset Management LLC | 1,437,302 | $14.7M |
| Iron Triangle Partners LP | 868,939 | $8.86M |
| Artal Group S.A. | 750,000 | $7.65M |
| Deep Track Capital, LP | 350,000 | $3.57M |
| Saturn V Capital Management LLC | 172,188 | $1.76M |
| Bank of Montreal | 162,148 | $1.74M |
| Norges Bank | 156,100 | $1.59M |
| Marshall Wace, LLP | 65,558 | $668.7K |
| Renaissance Technologies LLC | 56,500 | $576.0K |
| Prosight Management, LP | 42,537 | $433.9K |
| TD Asset Management Inc | 42,000 | $428.4K |
| HBK Investments L P | 30,000 | $306.0K |
| Voloridge Investment Management, LLC | 29,663 | $302.6K |
| Los Angeles Capital Management LLC | 26,749 | $272.8K |
| SG Americas Securities, LLC | 15,056 | $154.0K |
| Caas Capital Management LP | 14,383 | $146.7K |
| Gabelli Funds LLC | 10,433 | $106.4K |
| Sandia Investment Management LP | 5,000 | $51.0K |
| Cubist Systematic Strategies, LLC | 4,106 | $41.9K |
| Baillie Gifford & Co | 286 | $2.92K |
| Advisory Services Network, LLC | 229 | $2.34K |
| CWM, LLC | 2 | $0 |